Cat.#: ACPP-1281
| Despition | ULK1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1517 | Human PGRN Protein (AC1517) | 2 µg | inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1378 | Human EFNB3 Protein (AC1378) | 5 µg | inquiry |
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
| ACPP-1662 | Human POFUT1 Protein (AC1662) | 5 µg | inquiry |
| ACPP-1008 | Recombinant Human Siglec 7 Protein (6×His Tag) (AC1008) | 50 µg | inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1345 | DISC1 Blocking Peptide (AC1345) | 250 µg | inquiry |
| ACPP-1128 | Recombinant Human Vimentin Protein (AC1128) | 25 µl | inquiry |
| ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.